Seminars
Dec 7, 2026
Chemical reprogramming of committed myoblasts into myogenic progenitors with activated satellite cell characteristics
Speaker: Dr. Ori Bar-Nur
Associate Professor, Department of Health Sciences and Technology, Eidgenössische Technische Hochschule Zürich
School of Biomedical Sciences cordially invites you to join the following seminar:
Date: 7 December 2026 (Monday)
Time: 4:00 pm – 5:00 pm
Venue: Lecture Theatre 1, G/F, William M.W. Mong Block, 21 Sassoon Road
Host: Professor Ralf Jauch
Biography
Dr. Ori Bar-Nur is an Associate Professor of Regenerative and Muscle Biology in the Department of Health Sciences and Technology at ETH Zurich. He earned his PhD with distinction from the Hebrew University of Jerusalem and completed postdoctoral training at Harvard University. Dr. Bar-Nur’s research focuses on stem cell biology, skeletal muscle regeneration, and cellular reprogramming, aiming to develop new strategies for tissue repair, disease modeling, and regenerative medicine. To this end, his laboratory pioneered and applies direct reprogramming approaches to convert somatic cells into regenerative-competent myogenic progenitors suitable for potential therapeutic applications. He is the recipient of several competitive grants and honors as a principal investigator, including the Swiss National Science Foundation Eccellenza Grant, the Young Helmut Horten Investigator Award, and the Spark Award. His lab’s research has provided fundamental insights and translational advances in muscle and pluripotent stem cell research.
Abstract
Satellite cells are essential for muscle regeneration and give rise to committed myoblasts that lose muscle stem cell properties during expansion in vitro, limiting their utility in research and translational applications. Here, we show that a small-molecule cocktail targeting the cAMP, TGF-β and WNT signaling pathways converts committed mouse myoblasts into expandable satellite-like myogenic progenitor cells (MPCs). Using a novel dual-fluorescent Pax7/MyoD reporter, we demonstrate rapid dedifferentiation of Pax7+/MyoD+ myoblasts into Pax7+/MyoD- MPCs within days. This conversion induces muscle stem cell-associated genes and pathways, including Notch, EGFR, Calcr, and P53, while genetic ablation of Notch1-expressing cells selectively abrogates MPC cultures. Notably, single-cell transcriptomics further revealed that a subset of MPCs resembles self-renewing in vivo-derived activated satellite cells. Last, transplanted MPCs restored dystrophin expression in dystrophic mice and could be re-isolated to establish myoblast cultures. Together, these findings demonstrate that myoblast identity is reversible and can be chemically reset to generate myogenic progenitors with key molecular and functional attributes of satellite cells.
All are welcome.
New Releases
Oct 14, 2026
HKUMed SBMS and E-SENSE Innovation & Technology Forge Strategic Partnership to Advance Biomedical Imaging and Digital Health Solutions
Oct 8, 2026
Hong Kong’s Biotech Ecosystem Gains Momentum: HKUMed and Skyhore Collaborate to Drive Innovation and Cultivate Future Leaders in Microbiome Science
Sep 17, 2026
HKUMed School of Biomedical Sciences and Phase Scientific join forces to nurture Hong Kong's next-generation biomedical talent through academic-industry collaboration
Jun 8, 2026